PRO35 Characterization and Treatment of Immune Thrombocytopenia (ITP) in Europe: A Qualitative Observational Study
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1020
https://www.valueinhealthjournal.com/article/S1098-3015(21)01237-7/fulltext
Title :
PRO35 Characterization and Treatment of Immune Thrombocytopenia (ITP) in Europe: A Qualitative Observational Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01237-7&doi=10.1016/j.jval.2021.04.1020
First page :
Section Title :
Open access? :
No
Section Order :
10516